Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease - The William M. Steinberg Board Review in Gastroenterology and Best Practices Course

LOG IN | PURCHASE|ONLINE PRACTICE EXAMS (will open new tab)

You are currently viewing Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease

Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease

Post author:GIBoardReview.com
Post published: May 27, 2026
Post category:Society Guidelines

X